Showing results (1471-1480 of 4,521) with videos related to
Sort By:
Pageof 453
Future Oncology (London, England)|April 27, 2017
Role of everolimus in the treatment of metastatic HER2-negative/HR-positive breast cancerPaolo PronzatoFuture Oncology (London, England)|September 8, 2016
Promising novel therapeutic approaches in the management of gastrointestinal stromal tumorsZoltan Szucs, Khin Thway, Cyril Fisher, et al.Future Oncology (London, England)|July 8, 2017
Prognostic potential of neutrophil-to-lymphocyte ratio and lymphocyte nadir in stage III non-small-cell lung cancerKylie H Kang, Jimmy T Efird, Neelesh Sharma, et al.Future Oncology (London, England)|July 8, 2017
State of the ablation nation: a review of ablative therapies for cure in the treatment of hepatocellular carcinomaUmer Salati, Aisling Barry, Frank Y Chou, et al.Future Oncology (London, England)|July 8, 2017
What's new in small cell lung cancer - extensive disease? An overview on advances of systemic treatment in 2016Andreas Seeber, Christoph Leitner, Kathrin Philipp-Abbrederis, et al.Future Oncology (London, England)|July 8, 2017
Effect of cancer-associated fibroblasts on radiosensitivity of cancer cellsXiaoqin Ji, Xixu Zhu, Xueguan LuFuture Oncology (London, England)|June 19, 2018
Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USAVicki A Morrison, Jill A Bell, Laurie Hamilton, et al.Future Oncology (London, England)|July 14, 2018
Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyondHui-Li Wong, Michael Christie, Lucy Gately, et al.Future Oncology (London, England)|July 11, 2018
Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic valueJia Liu, Hanhua Dong, Yingxu Yang, et al.Future Oncology (London, England)|June 22, 2018
Nivolumab and its use in the second-line treatment of metastatic urothelial cancerDaniele Raggi, Andrea Necchi, Patrizia GiannatempoPageof 453